Todd Barnett
Todd A. Barnett, M.D.

Todd A. Barnett, M.D.

Todd A. Barnett, M.D.
Specialty

Oncology - Radiation

Clinical Interests / Special Procedures Performed

Breast Cancer, Gastrointestinal Cancer, Hodgkin's Disease, Lung Cancer, Lymphoma

  • Accepting Children: No
  • Accepting New Patients: Yes
  • Accepting Medicare: Yes
  • Accepting Medicaid/DSHS: Yes
Payment Methods Accepted:

Medicare, Medicaid/DSHS, Bill Insurance, VISA, Master Card, Cash, Check, American Express, Discover Card, Money Order

Insurance Accepted:

Contact this office for accepted insurance plans.

Additional Information:

HONORS

Dr. Barnett was voted "Top Doctors" in Seattle Metropolitan Magazine (2006, 2012)

Nearly 4,500 physicians, nurses and physician assistants in King, Kitsap and Snohomish counties nominated colleagues they would choose to treat themselves and their loved ones.

News Release

Dr. Barnett was voted "Top Doctors" in Seattle Magazine (2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012). 

A survey was mailed to more than 18,000 physicians in King, Pierce, Snohomish and Kitsap counties. The survey asked physicians to name the provider they would seek out or recommend to loved ones.

News Release


APPOINTMENTS

2011 - Present  Associate Executive Medical Director- Radiation Therapy Innovations
2000 - Present  Medical Director, Radiation Oncology—Swedish Cancer Institute
2000 - Present  Managing Partner, Tumor Institute Radiation Oncology Group
1993 - Present  Radiation Oncologist, Swedish Cancer Institute


PROFESSIONAL AFFILIATIONS

American Society for Therapeutic Radiology and Oncology (ASTRO)
American College of Radiology (ACR)
King County Medical Society
Washington State Radiological Society (WSRS)

Medical School

Northwestern University, IL

Residency

Stanford University, CA

Fellowship(s)

Stanford University, CA

Board Certifications

Board Certified in Radiation Oncology

Additional Information:

HONORS

Dr. Barnett was voted "Top Doctors" in Seattle Metropolitan Magazine (2006, 2012)

Nearly 4,500 physicians, nurses and physician assistants in King, Kitsap and Snohomish counties nominated colleagues they would choose to treat themselves and their loved ones.

News Release

Dr. Barnett was voted "Top Doctors" in Seattle Magazine (2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012). 

A survey was mailed to more than 18,000 physicians in King, Pierce, Snohomish and Kitsap counties. The survey asked physicians to name the provider they would seek out or recommend to loved ones.

News Release


APPOINTMENTS

2011 - Present  Associate Executive Medical Director- Radiation Therapy Innovations
2000 - Present  Medical Director, Radiation Oncology—Swedish Cancer Institute
2000 - Present  Managing Partner, Tumor Institute Radiation Oncology Group
1993 - Present  Radiation Oncologist, Swedish Cancer Institute


PROFESSIONAL AFFILIATIONS

American Society for Therapeutic Radiology and Oncology (ASTRO)
American College of Radiology (ACR)
King County Medical Society
Washington State Radiological Society (WSRS)

PUBLICATIONS:

Einstein Jr., AB, Yates, J, Kearney, C, Wong, T, Barnett TA. Evaluating and Selecting New linear Accelerator Technology. Oncology Issues 38-40. March/April 2006.

Barnett, TA, From EBRT to IMRT to IGRT, Advances in Radiation Therapy. Oncology Issues, 36-37. March/April 2006

Zaucha RE, Buckner DC, Barnett TA, Holmberg LA, Gooley T., Hooper HA, Maloney DG, Appelbaum F, Bensinger WI. Modified total body irradiation as planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies. Int J Radiation Oncology Biol Phys. 1:64(1): 227-34. Jan 2006

Anderson JE, Appelbaum FR, Schoch G, Barnett T. Chauncey TR, Flowers ME, Storb R. Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation. Biol Blood Marrow Transplant; 7(3): 163-70. 2001

Storb R, Sale G, Barnett T, Yu C, Zellmer E, Little MT. Transient mixed hematopoietic chimerism in dogs given thymic irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood. 1; 97(9): 2915-6. May 2001 

Hawkins D, Barnett T, Bensinger W, Gooley T, Sanders J. Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors. Med Pediatr Oncol. 34(5):328-37 May 2000

Storb R, Yu C, Barnett TA, Wagner JL, Deeg HJ, Nash RA, Kiem HP, McSweeney P, Seidel K, Georges G, Zaucha JM. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood. 94 (3):1131-6, 1999

Bensinger WI, Rowley SD, Demirer T, Lilleby K, Schiffman K, Clift RA, Appelbaum FR, Ferer A, Barnett T, Storb R, Chauncey T, Maziarz RT, Klarnet J, McSweeney P, Holmberg L, Maloney DG, Weaver CH, Buckner CD. High-dose therapy followed by autologous hematipoietic stemcell infusion for patients with multiple myeloma. J Clin Oncol 14(5): 1447-56 May 1996

Bensinger WI, Appelbaum FR, Rowley SD, Demirer T, Lilleby K, Schiffman K, Clift RA, Barnett TA, Storb, Chauncey R, Maziarz RT, Klarnet J, Gooley TA, Fiter A, McSweeney PA, Holmberg L, Maloney DG, Weaver CH, Buckner CD. Autologous Marrow or Peripheral Blook Stem Cell Transplantation for Patients with Multiple Myeloma. J. Clin. Oncol. 14:1447-1456; 1996

Bensinger WI, Buckner CD, Anasetti C, Clift R, Storb R, Gooley T, Barnett TA, Chauncey T, Shulman H, Appelbaum FR. Allogeneic Marrow Transplantation for Multiple Myeloma, an Analysis of Risk Factors on Outcome. Blood. 88:2787-2793; 1996

Demirer T, Petersen FB, Appelbaum FR, Barnett TA, Sanders J, Deeg HR, Storb R, Doney K, Bensinger WI, Shannon-Dorcy K, Buckner CD. Allogeneic Marrow Transplantation Following Cyclosphamide and Escalation Doses of Hyerfractionated Total Body Irradiation in Patients with Advanced Lymphoid Malignancies: A Phase I/II Clinical Trial. Int. J. Radiation Oncology Biol. Phys. 32:1103-1109; 1995

Kapp DS, Cox RS, Barnett TA, Ben-Yosef R. Thermoradiotherapy for residual microscopic cancer: Elective or post-excisional Hyperthermia and radiation therapy in the management of local-regional recurrent breast cancer. Int. J. Radiation Oncology Biol. Phys. 24:261-277; 1992

Barnett TA, Kapp DS. Reduction of pain and local complications when buffered lidocaine solution is used as a local anesthetic in conjunction with hyperthermia treatments: Results of randomized trial. Int. J. Radiation Oncology Biol. Phys. 23:585-591; 1992

Kapp DS, Barnett TA, Cox RS, Lee ER, Lohrbach A, Fessenden P. Hyperthermia and radiation therapy of local-regional recurrent breast cancer: Prognostic factors for response and local control of diffuse or nodular tumors. Int. J. Radiation Oncology Biol. Phys. 20:1147-1164; 1991

Kapp DS, Barnett TA, Cox RS, Lee ER, Lohrbach A, Fessenden P. Letter to the Editor. Int. J. Radiation Oncology Biol. Phys. 20:1145; 1991

Barnett TA, Kapp DS, Goffinet DR. Adenoid cystic carcinoma of the salivary glands: Management of recurrent, advanced, or persistent disease with hypothermia and radiation therapy. Cancer. 65:2648-2656; 1990

--------------------------------------------------------------------------------

ABSTRACTS:

Anderson JE, Appelbaum FR, Barnett TA, Chauncey TR, Flowers M, Storb R. Relapse after allogeneic bone marrow transplantation for Myelodysplasia subtype refractory anemia is increased by shielding lungs and during irradiation. Blood 92(suppl):659a (abstract no. 2720), 1998

Hawkins D, Sanders J, Bensinger W, Barnett TA. Busulfan, Melphalan, and Thiotepa (BuMelTt) +/- Total Marrow Irradiation (TMI) with hematopoietic Stem Cells (HSC) for Ewing’s Sarcoma Family Tumors. ASCO Proc., 1997, 16:521a

Barnett TA, Kapp DE. Reduction of pain and local complications when buffered lidocaine solution was used as a local anesthetic in conjunction with hyperthermia treatments: Results of a randomized trial. Chapman JD, Dewey WC, Whitmore GF, eds. Radiation Research – A Twentieth-Century Perspective. 1991 Academic Press, Inc., San Diego, CA, p. 391

Kapp DS, Barnett TA, Cox RS, et al. Prognostic Factors in Combined Hyperthermia-Radiation Therapy treatment of local-regional recurrent breast cancer: An analysis of eight years of clinical experience. ASTRO, 1990, Miami, FL

Barnett TA, Kapp DS. Adenoid cystic carcinomas (ACC) of the salivary glands: Response to radiation therapy and hyperthermia. Abstracts of Papers for the Thirty-Eighth Annual Meeting of the Radiation Research Society, New Orleans, Louisiana, April 7-10, 1990, p. 38

Offices

Radiation Oncology / First Hill - Swedish Cancer Institute
1221 Madison Street
Arnold Pavilion, 1st Floor
Seattle, WA 98104
Phone: 206-386-2323
Fax: 206-215-6150
Office Hours: Monday-Friday. 8 a.m.-4:30 p.m
Map & Directions

Physicians: Is this your profile? Click here for info